CCM
PTX

Cadence Capital Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Cadence Capital Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-13,847
Closed -$1.06M – 692
2014
Q3 		$1.06M Buy
+13,847
New +$1.09M 0.06% 385
2013
Q3 		– Sell
-8,707
Closed -$314K – 659
2013
Q2 		$314K Buy
+8,707
New +$326K 0.01% 367

Other funds holding PTX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cadence Capital Management's PTX Position: Q4 2014 in Review

Cadence Capital Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2014, closing a stake of 13,847 shares — an estimated $1.06M sold.

Cadence Capital Management first reported a position in PTX in Q2 2013 and held it in 2 quarters. The position peaked at $1.06M in Q3 2014. 97 funds tracked by Wall St. Rank hold PTX as of Q4 2014.

  • Cadence Capital Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2014 after selling out during the quarter.
  • Cadence Capital Management sold 13,847 Pernix Therapeutics Holdings, Inc. shares in Q4 2014, an estimated $1.06M.
  • Cadence Capital Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 2 quarters.
  • Cadence Capital Management's Pernix Therapeutics Holdings, Inc. position peaked at $1.06M in Q3 2014.
  • 97 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2014.

Based on Cadence Capital Management's 13F filing for Q4 2014, filed 3 Feb 2015.